UGT1A6 Antibody

說明書

中文名稱：

UGT1A6兔多克隆抗體
貨號：

CSB-PA230502
規(guī)格：

￥1100
圖片：
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA230502(UGT1A6 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)

The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CSB-PA230502(UGT1A6 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)
其他：

產(chǎn)品詳情
產(chǎn)品評價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

Uniprot No.：

P19224
基因名：

UGT1A6
別名：

UGT1A6; GNT1; UGT1; UDP-glucuronosyltransferase 1-6; UDPGT 1-6; UGT1*6; UGT1-06; UGT1.6; Phenol-metabolizing UDP-glucuronosyltransferase; UDP-glucuronosyltransferase 1-F; UGT-1F; UGT1F; UDP-glucuronosyltransferase 1A6
宿主：

Rabbit
反應(yīng)種屬：

Human
免疫原：

Synthetic peptide of Human UGT1A6
免疫原種屬：

Homo sapiens (Human)
標(biāo)記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

Antigen affinity purification
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA,IHC

推薦稀釋比：

Application	Recommended Dilution
ELISA	1:2000-1:5000
IHC	1:25-1:100

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價(jià)

靶點(diǎn)詳情

功能：

UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 3 lacks transferase activity but acts as a negative regulator of isoform 1.
基因功能參考文獻(xiàn)：
1. high activityUGT1A6 genotype is associated with an increased risk for Warthin's tumor PMID: 25899702
2. Rs28898617 (UGT1A6, A > G) variation was associated with an increase in NCVPA. PMID: 27855134
3. Oxidative stress and histone modifications may promote transcriptional activation of Ugt1a6 and Ugt1a7 genes. PMID: 26684499
4. Identified coding variants on UGT1A1 and UGT1A6 genes in association with serum bilirubin level and hyperbilirubinemia risk in elderly subjects. PMID: 26039129
5. Evaluating the association of UGT1A6 2 Ser7Ala polymorphism with drug response, there was no significant difference in the genotypic distribution between responders and non-responders. PMID: 24036429
6. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. PMID: 23441093
7. Lower adjusted plasma VPA concentrations were also observed in patients with UGT1A6 double heterozygosities than those with single heterozygosity. PMID: 23099353
8. UGT1A6 polymorphisms may be used to identify people with increased risk of developing lung cancer PMID: 22912755
9. Polymorphism in UDP-glucuronosyltransferase 1A6 is associated with colorectal cancer. PMID: 22901212
10. the protective T allele of rs17863783 was found to be associated with increased mRNA expression of UGT1A6.1; study suggests that rs17863783 may protect from bladder cancer by increasing the removal of carcinogens from bladder epithelium by the UGT1A6.1 protein PMID: 22228101
11. Dual polymorphisms of UDP glucuronosyl-transferases 1A6 and 1A1 in a patient with Gilbert's syndrome who had persistent hyperserotoninemia that responded to octreotide are reported. PMID: 22450351
12. analysis of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma PMID: 22030088
13. The percentage of APAP was higher among UGT1A6*1/*1 genotypes, relative to *1/*2 and *2/*2 genotypes (P = 0.045). PMID: 21666065
14. development of UGT1A1 and 1A6 was studied in 50 pediatric liver samples; data imply independent regulation of UGT1A1 and 1A6 where activity has matured after 6 months to 1 year PMID: 21266593
15. A positive association is found between UGT1A6 genotypes and the occurrence of anti-tuberculosis drug induced hepatic-injury. PMID: 21586239
16. evaluated cross-sectionally whether urinary excretion of ASA and its metabolites differed by UGT1A6 genotype and dietary factors shown to induce UGT PMID: 21625173
17. Letter: Results suggest that a small breast cancer risk conveyed by UGT1A1 and UGT1A6 variants may be further amplified by the experience of persisting stressful events. PMID: 20686835
18. The induction of UGT1A6 by methotrexate alone or in combination with other antineoplastics is reported. PMID: 20854796
19. Subjects carrying allele of MPO rs7208693 A and UGT1A6 rs6759892 G or rs1105879 C at the same time could be more susceptible to chronic benzene poisoning. PMID: 17424838
20. In a study of Japanese renal transplant recipients, there are no significant differences in the area under the plasma concentration-time curve ratio of mycophenolic acid glucuronide/MPA between UGT1A6 I399C/T genotypes. PMID: 18695635
21. The subjects carrying GSTP1rs947894 AG/GG genotypes and UGT1A6 rsl105879 AA genotypes could be more susceptible to vinyl chloride monomer-induced DNA damage. PMID: 19267064
22. UGT1A6 A541G gene polymorphism does not influence serum concentrations of valproic acid in Han epileptic children. PMID: 20540849
23. kinetic studies of UGT1A6 metabolizing psilocin (a hallucinogenic indole alkaloid) and 4-hydroxyindole PMID: 20007669
24. Data identified five different genotypes in UGT1A6, demonstrating a high variability of alleles and haplotypes, which have important roles in modifying expression and activity of UGTs. PMID: 19712005
25. relevance of cysteine 126 in the glucuronidation process PMID: 12009407
26. Most patients with Gilbert's syndrome may have abnormalities in glucuronidation of aspirin or coumarin- and dopamine-derivatives, due to this combination of UGT1A1*28 and UGT1A6*2 genotypes. PMID: 12480553
27. These results demonstrate for the first time glucuronidation of catechols by gastric and intestinal microsomal UGTs and three human recombinant UGT isoforms.Recombinant human UGT1A6, 1A9, and 2B7 effectively catalyzed catechol glucuronidation PMID: 12623074
28. Human UGT1A6 plays a predominant role in the glucuronidation of 5-hydroxytryptophol and N-acetylserotonin, whereas 6-hydroxymelatonin is not a substrate for this enzyme. PMID: 15258112
29. Genetic polymorphisms in UGT1A6 is associated with colorectal cancer PMID: 15319294
30. Genotyping of UGT1A6 in the Japanese, and probably other Asian populations. PMID: 15770079
31. Structure and function of UGT1A6 is reviewed. PMID: 16399343
32. Role of the Ah receptor in induction of enzyme UGT1A1 is reviewed. PMID: 16399344
33. Total or partial deletion of the stop transfer sequence of UGT1A6 severely impaired enzyme activity highlighting its importance in both membrane assembly and function. PMID: 16529747
34. Coinfections with UGT1A4 increased the normalized scopoletin glucuronidation of 6YD (the Y485D mutant of UGT1A6) much more than it affected 1YD (the Y486D mutant of UGT1A1). PMID: 17301691
35. Paracetamol disposition can be used as a probe to assess UGT1A6 ontogeny in the first months of life. PMID: 17609736
36. UGT1A6 is a major contributor to glucuronidation of apigenin but not genistein in intact Caco-2 cells and in cell lysates PMID: 17927138
37. HNF1alpha and HNF4alpha are the factors involved in the interindividual variability of liver UGT1A6 and UGT1A9 mRNA expression. PMID: 17965524
38. The studied single nucleotide polymorphisms in UGT1A6 do not appear to exert statistically significant effects on the single-dose pharmacokinetics of deferiprone. PMID: 18318774
39. In females receiving ASA, the presence of the UGT1A6*2 compared to the UGT1A6*1 homozygote genotype is associated with lower plasma levels of SA, indicating faster pharmacokinetics. PMID: 19262071
40. the N-terminal portion of UGT1A6 is an antigenic site; sera from autoimmune hepatitis type 1 patients reacted with amino acids in the sequence 33-37 (PQDGS) of the N-terminal of UGT1A6. PMID: 19356052
41. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation. PMID: 19406951
42. study does not support a role of COX2 and UGT1A6 genetic variations in the development of colon cancer PMID: 19437564
43. Oolymorphisms in UGT1A6 may contribute to interindividual and intra-ethnic differences, which may be helpful in the development of pharmacogenomics in China. PMID: 19450126
44. Single-nucleotide polymorphisms, T181A of the UGT1A6 gene is found to be significantly associated with the risk of asthma. PMID: 19575027
45. Genetic polymorphisms in UDP-glucuronosyltransferase 1A6 are not associated with NSAIDs-related peptic ulcer haemorrhage. PMID: 19799547
46. Observational study of gene-environment interaction and healthcare-related. (HuGE Navigator) PMID: 16305586
顯示更多

收起更多
亞細(xì)胞定位：

Microsome. Endoplasmic reticulum membrane; Single-pass membrane protein.
蛋白家族：

UDP-glycosyltransferase family
組織特異性：

Expressed in skin. Isoforms 1 and 3 are expressed in kidney and liver. Isoform 1 but not isoform 2 is expressed in colon, esophagus and small intestine.
數(shù)據(jù)庫鏈接：

HGNC: 12538

OMIM: 191740

KEGG: hsa:54578

STRING: 9606.ENSP00000303174

UniGene: Hs.554822

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human